|国家科技期刊平台
首页|期刊导航|疑难病杂志|自膨式瓣膜行导管主动脉瓣膜置换术治疗单纯主动脉瓣反流患者35例

自膨式瓣膜行导管主动脉瓣膜置换术治疗单纯主动脉瓣反流患者35例OACSTPCD

Transcatheter aortic valve replacement with self-expanding valve in the treatment of 35 patients with simple aortic re-gurgitation

中文摘要英文摘要

目的 评价主动脉瓣膜反流(AR)患者应用自膨式瓣膜行经导管主动脉瓣膜置换术(TAVR)的安全性及可行性.方法 回顾性分析 2019 年 8 月—2022 年 8 月于河北医科大学第二医院心脏外科应用自膨式瓣膜行TAVR的重度AR患者35 例,其中男25 例,女10 例,年龄59~83(70.03±1.07)岁.分析手术成功率、病死率、手术并发症发生率及术后患者左心功能变化.结果 35 例患者均采用自膨式介入瓣膜经股动脉行TAVR手术成功,成功率100%,无死亡病例.采用体外循环辅助完成手术的患者 17 例(48.6%),平均体外循环辅助时间(32.5±14.6)min.同期行经皮冠状动脉介入术(PCI)治疗的患者 5 例(14.3%).采用瓣中瓣技术的患者 14 例(40.0%).术前LVEF(48.01±12.20)%,术后1 周 LVEF(50.22±15.11)%,差异无统计学意义(t =0.552,P>0.05);术前左心室舒张末期内径(65.04±10.10)mm,术后1 周左心室舒张末期内径(63.44±11.03)mm,差异无统计学意义(t =0.710,P>0.05).术前5 例患者存在二尖瓣中量及以上反流,术后二尖瓣反流均较术前减轻,其中 2 例转为少中量反流,3 例转为少量反流.术后即刻出现完全性左束支传导阻滞 14 例(40.0%),三度传导阻滞 1 例(2.9%),转入心内科植入永久起搏器.术中出现心包积液 1 例(2.9%),胸骨正中剑突下切口植入心包引流管后痊愈.少中量瓣周漏 3 例(8.6%),其余为少量及微量瓣周反流32 例(91.4%).结论 应用自膨式瓣膜经股动脉行TAVR治疗重度主动脉瓣关闭不全患者手术安全性高,具有创伤小、并发症少、恢复快等优点.

Objective To evaluate the safety and feasibility of transcatheter aortic valve replacement(transcatheter aortic valve replacement,TAVR)in patients with aortic valve regurgitation(aortic regurgitation,AR).Methods Retrospec-tive analysis of 35 patients with severe AR in the Second Hospital of Hebei Medical University from August 2019 to August 2022,including 25 male and 10 female,aged 59 to 83(70.03±1.07).Surgical success rate,mortality rate,incidence of surgical complications and left heart function changes of postoperative patients were analyzed.Results All 35 patients underwent successful transfemoral TAVR procedures with the self-expanding interventional valve,with a 100%success rate and no deaths.17 patients(48.6%)completed the procedure with cardiopulmonary bypass assistance,with the mean time of cardiop-ulmonary bypass assistance(32.5±14.6)min.5 patients(14.3%)were treated with concurrent percutaneous coronary inter-vention(percutaneous coronary intervention,PCI).Fourteen(40.0%)patients used the mediumvalve technique.Preopera-tive LVEF(48.01±12.20)%,1 week LVEF(50.22±15.11)%(t=0.552,P>0.05),preoperative left ventricular end diastolic di-ameter(65.04±10.10)mm,and ventricular end diastolic diameter(63.44±11.03)mm(t=0.710,P>0.05).Before surgery,5 pa-tients had medium or above mitral regurgitation,and postoperative mitral regurgitation was reduced compared with preopera-tive patients.Among them,2 patients turned to small and medium regurgitation,and 3 patients turned to small regurgitation.Immediately aftersurgery,14 cases(40.0%)and 1 third degree block(2.9%)were transferred to cardiology with permanent pacemaker.One intraoperative pericardial effusion(2.9%)was recovered after implantation of the pericardial drainage tube in the median sternal subxiphoid incision.Lowand moderate paravalvular leakage was 3(8.6%);the remaining minor and trace regurgitation was 32(91.4%).Conclusion TAVRwith self-expansive valve via femoral artery is safe for patients with se-vere aortic regurgitation.It has the advantages of less trauma,fewer complications and faster recovery,and is worthy of clinical application.

王华君;吴雪达;石凤梧;刘苏;马千里;安景辉

050000 石家庄,河北医科大学第二医院心脏外科

临床医学

主动脉瓣反流主动脉瓣关闭不全经导管主动脉瓣膜置换术自膨式瓣膜治疗效果并发症

Aortic valve regurgitationAortic valve insufficiencyTranscatheter aortic valve replacemenSelf-ex-panding valveTreatment effectComplication

《疑难病杂志》 2024 (005)

532-536 / 5

河北省医学科学研究课题(20230440) Hebei Medical Science Research Project(20230440)

10.3969/j.issn.1671-6450.2024.05.005

评论